Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$92.37
0.250.27%
al cierre: -
$92.60
0.230.25%
After hour: 5:32 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Qorvo Inc ha un obiettivo di prezzo di consenso pari a $98.76, stabilito in base alle ultime valutazioni degli analisti di 27. Le ultime 3 valutazioni degli analisti sono state rilasciate da Loop Capital, UBS y Barclays il julio 30, 2025. Con un obiettivo di prezzo medio di $93.33 tra le Loop Capital, UBS y Barclays, c'è un implicito 0.79% upside per Qorvo Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Loop Capital
UBS
Barclays
Piper Sandler
Stifel
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Qorvo
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/30/2025 | -2.81% | Loop Capital | $75 → $90 | Maintains | Hold | |||
07/30/2025 | 7.99% | UBS | $95 → $100 | Maintains | Neutral | |||
07/30/2025 | -2.81% | Barclays | $70 → $90 | Maintains | Equal-Weight | |||
07/30/2025 | 34.99% | Piper Sandler | $110 → $125 | Maintains | Overweight | |||
07/30/2025 | -4.97% | Stifel | $75 → $88 | Maintains | Hold | |||
07/30/2025 | 2.59% | Susquehanna | $90 → $95 | Maintains | Neutral | |||
07/30/2025 | 34.99% | Benchmark | $95 → $125 | Maintains | Buy | |||
07/30/2025 | 12.31% | Needham | $90 → $104 | Maintains | Buy | |||
07/22/2025 | -2.81% | Susquehanna | $75 → $90 | Maintains | Neutral | |||
07/21/2025 | 2.59% | UBS | $75 → $95 | Maintains | Neutral | |||
07/10/2025 | -2.81% | Goldman Sachs | → $90 | Initiates | → Neutral | |||
07/01/2025 | -9.29% | Mizuho | $75 → $84 | Maintains | Neutral | |||
06/27/2025 | 18.79% | Piper Sandler | $110 → $110 | Reiterates | Overweight → Overweight | |||
04/30/2025 | -24.41% | Barclays | $60 → $70 | Maintains | Equal-Weight | |||
04/30/2025 | -19.01% | Loop Capital | $90 → $75 | Maintains | Hold | |||
04/30/2025 | 2.59% | Benchmark | → $95 | Upgrade | Hold → Buy | |||
04/30/2025 | -2.81% | Needham | $100 → $90 | Maintains | Buy | |||
04/22/2025 | -35.21% | Barclays | $80 → $60 | Maintains | Equal-Weight | |||
01/29/2025 | -2.81% | Loop Capital | $80 → $90 | Maintains | Hold | |||
01/29/2025 | -2.81% | Stifel | $95 → $90 | Maintains | Hold | |||
01/29/2025 | — | Benchmark | — | Reiterates | Hold → Hold | |||
01/29/2025 | -25.49% | Citigroup | $72 → $69 | Maintains | Sell | |||
01/29/2025 | 7.99% | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
01/27/2025 | 18.79% | Piper Sandler | $85 → $110 | Upgrade | Neutral → Overweight | |||
01/24/2025 | -2.81% | Mizuho | $80 → $90 | Maintains | Neutral | |||
01/21/2025 | 14.47% | Morgan Stanley | $90 → $106 | Upgrade | Equal-Weight → Overweight | |||
01/17/2025 | -13.61% | Barclays | $90 → $80 | Maintains | Equal-Weight | |||
01/10/2025 | -15.77% | Goldman Sachs | $99 → $78 | Maintains | Neutral | |||
01/07/2025 | -13.61% | Mizuho | $98 → $80 | Maintains | Neutral | |||
11/11/2024 | -21.17% | Loop Capital | → $73 | Initiates | → Hold | |||
10/30/2024 | -8.21% | TD Cowen | $125 → $85 | Maintains | Hold | |||
10/30/2024 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/30/2024 | -2.81% | Barclays | $120 → $90 | Maintains | Equal-Weight | |||
10/30/2024 | 2.59% | JP Morgan | $115 → $95 | Maintains | Underweight | |||
10/30/2024 | -8.21% | Piper Sandler | $100 → $85 | Reiterates | Neutral → Neutral | |||
10/30/2024 | -2.81% | UBS | $115 → $90 | Maintains | Neutral | |||
10/30/2024 | -2.81% | Susquehanna | $115 → $90 | Maintains | Neutral | |||
10/30/2024 | 13.39% | Craig-Hallum | $142 → $105 | Maintains | Buy | |||
10/30/2024 | -13.61% | B of A Securities | $115 → $80 | Maintains | Underperform | |||
10/30/2024 | 7.99% | Needham | $135 → $100 | Maintains | Buy | |||
10/30/2024 | — | Benchmark | — | Downgrade | Buy → Hold | |||
10/30/2024 | -13.61% | Exane BNP Paribas | → $80 | Downgrade | Outperform → Neutral | |||
10/25/2024 | 7.99% | Piper Sandler | $120 → $100 | Maintains | Neutral | |||
10/21/2024 | 24.19% | Susquehanna | $135 → $115 | Maintains | Neutral | |||
10/11/2024 | 29.59% | Morgan Stanley | $130 → $120 | Downgrade | Overweight → Equal-Weight | |||
10/10/2024 | 29.59% | Barclays | $125 → $120 | Maintains | Equal-Weight | |||
07/31/2024 | 34.99% | TD Cowen | $110 → $125 | Maintains | Hold | |||
07/31/2024 | 24.19% | JP Morgan | $100 → $115 | Maintains | Underweight | |||
07/31/2024 | 45.79% | Raymond James | $115 → $135 | Maintains | Outperform | |||
07/31/2024 | 53.35% | Craig-Hallum | $125 → $142 | Maintains | Buy | |||
07/31/2024 | 27.43% | Goldman Sachs | $105 → $118 | Maintains | Neutral | |||
07/31/2024 | 29.59% | Rosenblatt | $105 → $120 | Maintains | Neutral | |||
07/31/2024 | 29.59% | Piper Sandler | $105 → $120 | Reiterates | Neutral → Neutral | |||
07/31/2024 | 45.79% | Susquehanna | $145 → $135 | Maintains | Neutral | |||
07/31/2024 | 45.79% | Needham | $110 → $135 | Maintains | Buy | |||
07/30/2024 | 34.99% | Barclays | $100 → $125 | Maintains | Equal-Weight | |||
07/17/2024 | 56.59% | Susquehanna | $95 → $145 | Maintains | Neutral | |||
06/12/2024 | 13.39% | Rosenblatt | $105 → $105 | Maintains | Neutral | |||
06/12/2024 | 18.79% | Needham | $110 → $110 | Reiterates | Buy → Buy | |||
05/03/2024 | 13.39% | Goldman Sachs | $117 → $105 | Maintains | Neutral | |||
05/02/2024 | 7.99% | Barclays | $110 → $100 | Maintains | Equal-Weight | |||
05/02/2024 | 7.99% | JP Morgan | $105 → $100 | Maintains | Underweight | |||
05/02/2024 | 38.23% | Benchmark | $136 → $128 | Maintains | Buy | |||
05/02/2024 | 2.59% | Susquehanna | $100 → $95 | Maintains | Neutral | |||
05/02/2024 | 13.39% | Mizuho | $115 → $105 | Maintains | Neutral | |||
05/02/2024 | 18.79% | Needham | $125 → $110 | Maintains | Buy | |||
04/08/2024 | 7.99% | Susquehanna | → $100 | Maintains | Neutral | |||
02/02/2024 | 26.35% | Goldman Sachs | $104 → $117 | Maintains | Neutral | |||
02/01/2024 | 34.99% | Needham | $125 → $125 | Reiterates | Buy → Buy | |||
02/01/2024 | 13.39% | Piper Sandler | $120 → $105 | Maintains | Neutral | |||
02/01/2024 | 13.39% | Rosenblatt | $95 → $105 | Maintains | Neutral | |||
02/01/2024 | 29.59% | Raymond James | $115 → $120 | Maintains | Outperform | |||
02/01/2024 | 13.39% | JP Morgan | $95 → $105 | Maintains | Underweight | |||
02/01/2024 | 26.35% | Goldman Sachs | $104 → $117 | Maintains | Neutral | |||
01/19/2024 | 24.19% | Raymond James | $105 → $115 | Maintains | Outperform | |||
01/16/2024 | 7.99% | Barclays | $95 → $100 | Maintains | Equal-Weight | |||
01/04/2024 | 29.59% | Piper Sandler | → $120 | Downgrade | Overweight → Neutral | |||
12/08/2023 | 44.71% | Morgan Stanley | $120 → $134 | Upgrade | Equal-Weight → Overweight | |||
11/03/2023 | 7.99% | BMO Capital | $110 → $100 | Maintains | Market Perform | |||
11/03/2023 | 4.75% | Mizuho | $107 → $97 | Maintains | Neutral | |||
11/02/2023 | 2.59% | JP Morgan | $110 → $95 | Maintains | Underweight | |||
11/02/2023 | 29.59% | Morgan Stanley | $116 → $120 | Maintains | Equal-Weight | |||
11/02/2023 | 13.39% | Raymond James | $125 → $105 | Maintains | Outperform | |||
11/02/2023 | 2.59% | Barclays | $110 → $95 | Maintains | Equal-Weight | |||
11/02/2023 | — | Summit Insights Group | — | Downgrade | Buy → Hold | |||
10/24/2023 | 2.59% | Susquehanna | $110 → $95 | Maintains | Neutral | |||
10/10/2023 | -15.77% | Citigroup | $116 → $78 | Downgrade | Neutral → Sell | |||
08/03/2023 | 34.99% | Raymond James | $120 → $125 | Maintains | Outperform | |||
08/03/2023 | 25.27% | Morgan Stanley | $111 → $116 | Maintains | Equal-Weight | |||
08/03/2023 | 18.79% | Wells Fargo | $100 → $110 | Maintains | Equal-Weight | |||
08/03/2023 | 18.79% | Susquehanna | $105 → $110 | Maintains | Neutral | |||
08/03/2023 | 2.59% | Rosenblatt | → $95 | Reiterates | Neutral → Neutral | |||
08/03/2023 | 34.99% | Needham | → $125 | Reiterates | Buy → Buy | |||
08/03/2023 | 45.79% | Exane BNP Paribas | → $135 | Upgrade | Neutral → Outperform | |||
07/20/2023 | 34.99% | Wolfe Research | → $125 | Initiates | → Outperform | |||
07/19/2023 | -8.21% | Rosenblatt | → $85 | Reiterates | Neutral → Neutral | |||
06/22/2023 | 10.15% | Mizuho | → $102 | Reiterates | Neutral → Neutral | |||
05/05/2023 | 11.23% | Citigroup | $113 → $103 | Maintains | Neutral | |||
05/04/2023 | 18.79% | BMO Capital | $105 → $110 | Maintains | Market Perform | |||
05/04/2023 | 19.87% | Morgan Stanley | $110 → $111 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Qorvo (QRVO)?
El último precio objetivo de Qorvo (NASDAQ:QRVO) fue comunicado por Loop Capital el julio 30, 2025. La firma de analistas fijó un precio objetivo para $90.00 que espera QRVO a fall dentro de 12 meses (un posible -2.81% downside). 46 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Qorvo (QRVO)?
La última calificación de analistas para Qorvo (NASDAQ:QRVO) fue proporcionada por Loop Capital, y Qorvo mantuvo su hold calificación.
¿Cuándo se produjo la última revisión al alza de Qorvo (QRVO)?
La última revisión al alza de Qorvo Inc se produjo en abril 30, 2025, cuando Benchmark elevó su precio objetivo a $95. Benchmark anteriormente tenía a hold para Qorvo Inc.
¿Cuándo fue la última revisión a la baja de Qorvo (QRVO)?
La última revisión a la baja de Qorvo Inc se produjo en octubre 30, 2024, cuando Raymond James cambió su precio objetivo de N/A a N/A para Qorvo Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Qorvo (QRVO)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Qorvo, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Qorvo se registró el julio 30, 2025, por lo que la próxima calificación estará disponible en torno al julio 30, 2026.
¿Es correcta la calificación de los analistas sobre Qorvo (QRVO)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Qorvo (QRVO) fue un mantuvo con un precio objetivo de $75.00 a $90.00. El precio actual al que cotiza Qorvo (QRVO) es de $92.60, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.